CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Managing Data in Digital Clinical Trials

Managing Data in Digital Clinical...

Israel-Based Clearmind Medicine Offers First Clinical Center for Alcohol Use Disorder Trial

Israel-Based Clearmind Medicine...

Adagene Offers Clinical Trial Collaboration to Evaluate Roche's Standard-of-Care for First-Line Advanced Liver Cancer

Adagene Offers Clinical Trial...

Outsourcing the Potential Laboratory Services To Ensure Maximum Efficacy of Trials

Outsourcing the Potential Laboratory...

Accessing Sensitive Research Data Via European Genome-Phenome Archive(EGA)

Accessing Sensitive Research Data Via...

Boosting Clinical Cooperation for Improved Efficacy of Clinical Trials

Boosting Clinical Cooperation for...

Clinical Trials Climate in EU to Upsurge in the Future

Clinical Trials Climate in EU to...

Top Clinical Lab Equipment and Supply Chain Trends to Watch out for in 2022

Top Clinical Lab Equipment and Supply...

Managing Data in Digital Clinical Trials

Managing Data in Digital Clinical...

Israel-Based Clearmind Medicine Offers First Clinical Center for Alcohol Use Disorder Trial

Israel-Based Clearmind Medicine...

Adagene Offers Clinical Trial Collaboration to Evaluate Roche's Standard-of-Care for First-Line Advanced Liver Cancer

Adagene Offers Clinical Trial...

Outsourcing the Potential Laboratory Services To Ensure Maximum Efficacy of Trials

Outsourcing the Potential Laboratory...

Accessing Sensitive Research Data Via European Genome-Phenome Archive(EGA)

Accessing Sensitive Research Data Via...

Boosting Clinical Cooperation for Improved Efficacy of Clinical Trials

Boosting Clinical Cooperation for...

Clinical Trials Climate in EU to Upsurge in the Future

Clinical Trials Climate in EU to...

Top Clinical Lab Equipment and Supply Chain Trends to Watch out for in 2022

Top Clinical Lab Equipment and Supply...

Adherehealth and Levrx Technology Establish a Strategic Partnership to Improve Medication Optimization

Life Sciences Review | Tuesday, February 01, 2022
Tweet

Levrx is a forward-thinking software company transforming the healthcare experience one prescription at a time. Levrx connects providers, patients, pharmacies, and payers on a single platform to make prescribing easier and more affordable.


Fremont, CA: AdhereHealth, a healthcare technology company that drives prescription efficiencies and maximizes savings, formed a new integration partnership with Levrx Technology Inc today. This digital health technology company drives prescription efficiencies and maximizes savings. By integrating Levrx's plan-specific and real-time prescription insights into the Adhere Platform's Medication Optimization solution, their combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions.


The rising cost of pharmacy is one of the most significant challenges in American healthcare. According to the Centers for Medicare and Medicaid Services (CMS), prescription spending for private insurance and state-run programs was $348.4 billion in 2020, according to the Centers for Medicare and Medicaid Services (CMS), and is expected to reach $560.3 billion by 2028. As total costs continue to rise, member cost-sharing increases, as does concern medication non-adherence. According to statistics, at least 12.8 million adults delayed or did not obtain prescription drugs in 2018-19 due to cost.


"When prescriptions exceed $125, more than half of them are abandoned at the pharmacy," said Jason Z. Rose, CEO of AdhereHealth. "Our Medication Optimization solution now includes formulary cost savings analytics and technologies, 


which address lower-cost medication options for the patient, health plan, and employer, thanks to our collaboration with Levrx. These insights can be used by care teams to improve medication adherence and deliver immediate and long-term cost savings."


The Medication Optimization solution, anchored within the Adhere PlatformTM, generates insights based on medical claims, pharmacy claims, and direct patient and provider engagement to identify patients at high risk of non-adherence automatically. To prioritize high-risk patients and guide personalized outreach, the system generates targeted analytics that is updated daily and integrated into various clinical workflows. Predictive analytics insights provide actionable insights to care teams as they engage high-risk patients to close critical medication optimization gaps.


AdhereHealth can now increase its impact by incorporating prescription formulary opportunity analytics into its data-driven medication optimization workflow, thanks to the addition of Levrx capabilities. The Adhere Platform uses these analytics to notify clinicians when lower-cost alternatives are available. As a result, the provider is given the authority to proactively coordinate with the patient and the provider to prescribe the appropriate medication, reduce non-adherence, and improve health outcomes. The Adhere Platform's analytics, on the other hand, is integrated into Levrx Practice AppTM technology workflows for providers.


Weekly Brief

loading

  • Top 10 Clinical Trial Services Companies - 2022
  • Top 10 Emerging Clinical Trial Management Companies - 2022
  • Top 10 Clinical Trial Management System Companies - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/adherehealth-and-levrx-technology-establish-a-strategic-partnership-to-improve-medication-optimization-nwid-706.html